APO Research
Talk to an analyst

APO RESEARCH · REPORT

Saxagliptin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Saxagliptin Market Analysis and Forecast 2026-2032

26 December 2025195 pages

Choose your research edition.

Industry ResearchSaxagliptin Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Saxagliptin Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Saxagliptin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Saxagliptin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Saxagliptin Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Saxagliptin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Saxagliptin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Saxagliptin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Saxagliptin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Saxagliptin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Saxagliptin include Bristol-Myers Squibb Company, Minxiang Pharma, Taizhou Canova Bio-technology, Tapi Teva, AstraZeneca, Hebei Kangtai Pharma, Huaman Xincaiiao Keji and Tianjin Scipharmacn, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Saxagliptin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Saxagliptin, also provides the sales of main regions and countries. Of the upcoming market potential for Saxagliptin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Saxagliptin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Saxagliptin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Saxagliptin sales, projected growth trends, production technology, application and end-user industry.

Saxagliptin Segment by Company

Bristol-Myers Squibb Company

Minxiang Pharma

Taizhou Canova Bio-technology

Tapi Teva

AstraZeneca

Hebei Kangtai Pharma

Huaman Xincaiiao Keji

Tianjin Scipharmacn

Saxagliptin Segment by Type

2.5mg

5mg

Saxagliptin Segment by Application

Hospital

Clinic

Others

Saxagliptin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Saxagliptin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Saxagliptin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Saxagliptin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Saxagliptin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Saxagliptin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Saxagliptin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Saxagliptin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 2.5mg Major Manufacturers Table 3. 5mg Major Manufacturers Table 4. Global Saxagliptin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Others Major Manufacturers Table 8. Saxagliptin Industry Trends Table 9. Saxagliptin Industry Drivers Table 10. Saxagliptin Industry Opportunities and Challenges Table 11. Saxagliptin Industry Restraints Table 12. Global Saxagliptin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Saxagliptin Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Saxagliptin Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Saxagliptin Revenue Market Share by Region (2021-2026) Table 16. Global Saxagliptin Revenue Market Share by Region (2027-2032) Table 17. Global Saxagliptin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Saxagliptin Sales by Region (2021-2026) & (K Units) Table 19. Global Saxagliptin Sales by Region (2027-2032) & (K Units) Table 20. Global Saxagliptin Sales Market Share by Region (2021-2026) Table 21. Global Saxagliptin Sales Market Share by Region (2027-2032) Table 22. Global Saxagliptin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Saxagliptin Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Saxagliptin Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Saxagliptin Sales Market Share by Manufacturers (2021-2026) Table 26. Global Saxagliptin Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Saxagliptin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Saxagliptin Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Saxagliptin Manufacturers, Product Type & Application Table 30. Global Saxagliptin Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Saxagliptin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Saxagliptin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Saxagliptin Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Saxagliptin Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Saxagliptin Revenue Market Share by Type (2021-2026) Table 37. Global Saxagliptin Revenue Market Share by Type (2027-2032) Table 38. Global Saxagliptin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Saxagliptin Sales by Type (2021-2026) & (K Units) Table 40. Global Saxagliptin Sales by Type (2027-2032) & (K Units) Table 41. Global Saxagliptin Sales Market Share by Type (2021-2026) Table 42. Global Saxagliptin Sales Market Share by Type (2027-2032) Table 43. Global Saxagliptin Price by Type (2021-2026) & (US$/Unit) Table 44. Global Saxagliptin Price by Type (2027-2032) & (US$/Unit) Table 45. Global Saxagliptin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Saxagliptin Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Saxagliptin Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Saxagliptin Revenue Market Share by Application (2021-2026) Table 49. Global Saxagliptin Revenue Market Share by Application (2027-2032) Table 50. Global Saxagliptin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Saxagliptin Sales by Application (2021-2026) & (K Units) Table 52. Global Saxagliptin Sales by Application (2027-2032) & (K Units) Table 53. Global Saxagliptin Sales Market Share by Application (2021-2026) Table 54. Global Saxagliptin Sales Market Share by Application (2027-2032) Table 55. Global Saxagliptin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Saxagliptin Price by Application (2027-2032) & (US$/Unit) Table 57. Bristol-Myers Squibb Company Company Information Table 58. Bristol-Myers Squibb Company Business Overview Table 59. Bristol-Myers Squibb Company Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Bristol-Myers Squibb Company Saxagliptin Product Portfolio Table 61. Bristol-Myers Squibb Company Recent Development Table 62. Minxiang Pharma Company Information Table 63. Minxiang Pharma Business Overview Table 64. Minxiang Pharma Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Minxiang Pharma Saxagliptin Product Portfolio Table 66. Minxiang Pharma Recent Development Table 67. Taizhou Canova Bio-technology Company Information Table 68. Taizhou Canova Bio-technology Business Overview Table 69. Taizhou Canova Bio-technology Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Taizhou Canova Bio-technology Saxagliptin Product Portfolio Table 71. Taizhou Canova Bio-technology Recent Development Table 72. Tapi Teva Company Information Table 73. Tapi Teva Business Overview Table 74. Tapi Teva Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Tapi Teva Saxagliptin Product Portfolio Table 76. Tapi Teva Recent Development Table 77. AstraZeneca Company Information Table 78. AstraZeneca Business Overview Table 79. AstraZeneca Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. AstraZeneca Saxagliptin Product Portfolio Table 81. AstraZeneca Recent Development Table 82. Hebei Kangtai Pharma Company Information Table 83. Hebei Kangtai Pharma Business Overview Table 84. Hebei Kangtai Pharma Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Hebei Kangtai Pharma Saxagliptin Product Portfolio Table 86. Hebei Kangtai Pharma Recent Development Table 87. Huaman Xincaiiao Keji Company Information Table 88. Huaman Xincaiiao Keji Business Overview Table 89. Huaman Xincaiiao Keji Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Huaman Xincaiiao Keji Saxagliptin Product Portfolio Table 91. Huaman Xincaiiao Keji Recent Development Table 92. Tianjin Scipharmacn Company Information Table 93. Tianjin Scipharmacn Business Overview Table 94. Tianjin Scipharmacn Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Tianjin Scipharmacn Saxagliptin Product Portfolio Table 96. Tianjin Scipharmacn Recent Development Table 97. North America Saxagliptin Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Saxagliptin Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Saxagliptin Sales by Type (2021-2026) & (K Units) Table 100. North America Saxagliptin Sales by Type (2027-2032) & (K Units) Table 101. North America Saxagliptin Sales Price by Type (2021-2026) & (US$/Unit) Table 102. North America Saxagliptin Sales Price by Type (2027-2032) & (US$/Unit) Table 103. North America Saxagliptin Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Saxagliptin Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Saxagliptin Sales by Application (2021-2026) & (K Units) Table 106. North America Saxagliptin Sales by Application (2027-2032) & (K Units) Table 107. North America Saxagliptin Sales Price by Application (2021-2026) & (US$/Unit) Table 108. North America Saxagliptin Sales Price by Application (2027-2032) & (US$/Unit) Table 109. North America Saxagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Saxagliptin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. North America Saxagliptin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. North America Saxagliptin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 113. North America Saxagliptin Sales by Country (2021-2026) & (K Units) Table 114. North America Saxagliptin Sales by Country (2027-2032) & (K Units) Table 115. North America Saxagliptin Sales Price by Country (2021-2026) & (US$/Unit) Table 116. North America Saxagliptin Sales Price by Country (2027-2032) & (US$/Unit) Table 117. United States Saxagliptin Revenue (2021-2032) & (US$ Million) Table 118. Canada Saxagliptin Revenue (2021-2032) & (US$ Million) Table 119. Mexico Saxagliptin Revenue (2021-2032) & (US$ Million) Table 120. Europe Saxagliptin Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Saxagliptin Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Saxagliptin Sales by Type (2021-2026) & (K Units) Table 123. Europe Saxagliptin Sales by Type (2027-2032) & (K Units) Table 124. Europe Saxagliptin Sales Price by Type (2021-2026) & (US$/Unit) Table 125. Europe Saxagliptin Sales Price by Type (2027-2032) & (US$/Unit) Table 126. Europe Saxagliptin Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Saxagliptin Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Saxagliptin Sales by Application (2021-2026) & (K Units) Table 129. Europe Saxagliptin Sales by Application (2027-2032) & (K Units) Table 130. Europe Saxagliptin Sales Price by Application (2021-2026) & (US$/Unit) Table 131. Europe Saxagliptin Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Europe Saxagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Saxagliptin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe Saxagliptin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe Saxagliptin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 136. Europe Saxagliptin Sales by Country (2021-2026) & (K Units) Table 137. Europe Saxagliptin Sales by Country (2027-2032) & (K Units) Table 138. Europe Saxagliptin Sales Price by Country (2021-2026) & (US$/Unit) Table 139. Europe Saxagliptin Sales Price by Country (2027-2032) & (US$/Unit) Table 140. Germany Saxagliptin Revenue (2021-2032) & (US$ Million) Table 141. France Saxagliptin Revenue (2021-2032) & (US$ Million) Table 142. U.K. Saxagliptin Revenue (2021-2032) & (US$ Million) Table 143. Italy Saxagliptin Revenue (2021-2032) & (US$ Million) Table 144. Russia Saxagliptin Revenue (2021-2032) & (US$ Million) Table 145. Spain Saxagliptin Revenue (2021-2032) & (US$ Million) Table 146. Netherlands Saxagliptin Revenue (2021-2032) & (US$ Million) Table 147. Switzerland Saxagliptin Revenue (2021-2032) & (US$ Million) Table 148. Sweden Saxagliptin Revenue (2021-2032) & (US$ Million) Table 149. Poland Saxagliptin Revenue (2021-2032) & (US$ Million) Table 150. China Saxagliptin Revenue by Type (2021-2026) & (US$ Million) Table 151. China Saxagliptin Revenue by Type (2027-2032) & (US$ Million) Table 152. China Saxagliptin Sales by Type (2021-2026) & (K Units) Table 153. China Saxagliptin Sales by Type (2027-2032) & (K Units) Table 154. China Saxagliptin Sales Price by Type (2021-2026) & (US$/Unit) Table 155. China Saxagliptin Sales Price by Type (2027-2032) & (US$/Unit) Table 156. China Saxagliptin Revenue by Application (2021-2026) & (US$ Million) Table 157. China Saxagliptin Revenue by Application (2027-2032) & (US$ Million) Table 158. China Saxagliptin Sales by Application (2021-2026) & (K Units) Table 159. China Saxagliptin Sales by Application (2027-2032) & (K Units) Table 160. China Saxagliptin Sales Price by Application (2021-2026) & (US$/Unit) Table 161. China Saxagliptin Sales Price by Application (2027-2032) & (US$/Unit) Table 162. Asia Saxagliptin Revenue by Type (2021-2026) & (US$ Million) Table 163. Asia Saxagliptin Revenue by Type (2027-2032) & (US$ Million) Table 164. Asia Saxagliptin Sales by Type (2021-2026) & (K Units) Table 165. Asia Saxagliptin Sales by Type (2027-2032) & (K Units) Table 166. Asia Saxagliptin Sales Price by Type (2021-2026) & (US$/Unit) Table 167. Asia Saxagliptin Sales Price by Type (2027-2032) & (US$/Unit) Table 168. Asia Saxagliptin Revenue by Application (2021-2026) & (US$ Million) Table 169. Asia Saxagliptin Revenue by Application (2027-2032) & (US$ Million) Table 170. Asia Saxagliptin Sales by Application (2021-2026) & (K Units) Table 171. Asia Saxagliptin Sales by Application (2027-2032) & (K Units) Table 172. Asia Saxagliptin Sales Price by Application (2021-2026) & (US$/Unit) Table 173. Asia Saxagliptin Sales Price by Application (2027-2032) & (US$/Unit) Table 174. Asia Saxagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Asia Saxagliptin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. Asia Saxagliptin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. Asia Saxagliptin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 178. Asia Saxagliptin Sales by Country (2021-2026) & (K Units) Table 179. Asia Saxagliptin Sales by Country (2027-2032) & (K Units) Table 180. Asia Saxagliptin Sales Price by Country (2021-2026) & (US$/Unit) Table 181. Asia Saxagliptin Sales Price by Country (2027-2032) & (US$/Unit) Table 182. Japan Saxagliptin Revenue (2021-2032) & (US$ Million) Table 183. South Korea Saxagliptin Revenue (2021-2032) & (US$ Million) Table 184. India Saxagliptin Revenue (2021-2032) & (US$ Million) Table 185. Australia Saxagliptin Revenue (2021-2032) & (US$ Million) Table 186. Taiwan Saxagliptin Revenue (2021-2032) & (US$ Million) Table 187. Southeast Asia Saxagliptin Revenue (2021-2032) & (US$ Million) Table 188. SAMEA Saxagliptin Revenue by Type (2021-2026) & (US$ Million) Table 189. SAMEA Saxagliptin Revenue by Type (2027-2032) & (US$ Million) Table 190. SAMEA Saxagliptin Sales by Type (2021-2026) & (K Units) Table 191. SAMEA Saxagliptin Sales by Type (2027-2032) & (K Units) Table 192. SAMEA Saxagliptin Sales Price by Type (2021-2026) & (US$/Unit) Table 193. SAMEA Saxagliptin Sales Price by Type (2027-2032) & (US$/Unit) Table 194. SAMEA Saxagliptin Revenue by Application (2021-2026) & (US$ Million) Table 195. SAMEA Saxagliptin Revenue by Application (2027-2032) & (US$ Million) Table 196. SAMEA Saxagliptin Sales by Application (2021-2026) & (K Units) Table 197. SAMEA Saxagliptin Sales by Application (2027-2032) & (K Units) Table 198. SAMEA Saxagliptin Sales Price by Application (2021-2026) & (US$/Unit) Table 199. SAMEA Saxagliptin Sales Price by Application (2027-2032) & (US$/Unit) Table 200. SAMEA Saxagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. SAMEA Saxagliptin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. SAMEA Saxagliptin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. SAMEA Saxagliptin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 204. SAMEA Saxagliptin Sales by Country (2021-2026) & (K Units) Table 205. SAMEA Saxagliptin Sales by Country (2027-2032) & (K Units) Table 206. SAMEA Saxagliptin Sales Price by Country (2021-2026) & (US$/Unit) Table 207. SAMEA Saxagliptin Sales Price by Country (2027-2032) & (US$/Unit) Table 208. Brazil Saxagliptin Revenue (2021-2032) & (US$ Million) Table 209. Argentina Saxagliptin Revenue (2021-2032) & (US$ Million) Table 210. Chile Saxagliptin Revenue (2021-2032) & (US$ Million) Table 211. Colombia Saxagliptin Revenue (2021-2032) & (US$ Million) Table 212. Peru Saxagliptin Revenue (2021-2032) & (US$ Million) Table 213. Saudi Arabia Saxagliptin Revenue (2021-2032) & (US$ Million) Table 214. Israel Saxagliptin Revenue (2021-2032) & (US$ Million) Table 215. UAE Saxagliptin Revenue (2021-2032) & (US$ Million) Table 216. Turkey Saxagliptin Revenue (2021-2032) & (US$ Million) Table 217. Iran Saxagliptin Revenue (2021-2032) & (US$ Million) Table 218. Egypt Saxagliptin Revenue (2021-2032) & (US$ Million) Table 219. Key Raw Materials Table 220. Raw Materials Key Suppliers Table 221. Saxagliptin Distributors List Table 222. Saxagliptin Customers List Table 223. Research Programs/Design for This Report Table 224. Authors List of This Report Table 225. Secondary Sources Table 226. Primary Sources List of Figures Figure 1. Saxagliptin Image Figure 2. Global Saxagliptin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Saxagliptin Market Size Share 2021 VS 2025 VS 2032 Figure 4. 2.5mg Image Figure 5. 5mg Image Figure 6. Global Saxagliptin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Saxagliptin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Saxagliptin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Saxagliptin Revenue (2021-2032) & (US$ Million) Figure 13. Global Saxagliptin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Saxagliptin Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Saxagliptin Revenue Market Share by Region (2021-2032) Figure 16. Global Saxagliptin Sales (2021-2032) & (K Units) Figure 17. Global Saxagliptin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Saxagliptin Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Saxagliptin Sales YoY (2021-2032) & (K Units) Figure 20. Europe Saxagliptin Sales YoY (2021-2032) & (K Units) Figure 21. China Saxagliptin Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Saxagliptin Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Saxagliptin Sales YoY (2021-2032) & (K Units) Figure 24. Global Saxagliptin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Saxagliptin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Saxagliptin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Saxagliptin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Saxagliptin Revenue Market Share by Type (2021-2032) Figure 30. Global Saxagliptin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Saxagliptin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Saxagliptin Sales Market Share by Type (2021-2032) Figure 33. Global Saxagliptin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Saxagliptin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Saxagliptin Revenue Market Share by Application (2021-2032) Figure 36. Global Saxagliptin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Saxagliptin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Saxagliptin Sales Market Share by Application (2021-2032) Figure 39. North America Saxagliptin Revenue Share by Type (2021-2032) Figure 40. North America Saxagliptin Sales Share by Type (2021-2032) Figure 41. North America Saxagliptin Revenue Share by Application (2021-2032) Figure 42. North America Saxagliptin Sales Share by Application (2021-2032) Figure 43. North America Saxagliptin Revenue Share by Country (2021-2032) Figure 44. North America Saxagliptin Sales Share by Country (2021-2032) Figure 45. Europe Saxagliptin Revenue Share by Type (2021-2032) Figure 46. Europe Saxagliptin Sales Share by Type (2021-2032) Figure 47. Europe Saxagliptin Revenue Share by Application (2021-2032) Figure 48. Europe Saxagliptin Sales Share by Application (2021-2032) Figure 49. Europe Saxagliptin Revenue Share by Country (2021-2032) Figure 50. Europe Saxagliptin Sales Share by Country (2021-2032) Figure 51. China Saxagliptin Revenue Share by Type (2021-2032) Figure 52. China Saxagliptin Sales Share by Type (2021-2032) Figure 53. China Saxagliptin Revenue Share by Application (2021-2032) Figure 54. China Saxagliptin Sales Share by Application (2021-2032) Figure 55. Asia Saxagliptin Revenue Share by Type (2021-2032) Figure 56. Asia Saxagliptin Sales Share by Type (2021-2032) Figure 57. Asia Saxagliptin Revenue Share by Application (2021-2032) Figure 58. Asia Saxagliptin Sales Share by Application (2021-2032) Figure 59. Asia Saxagliptin Revenue Share by Country (2021-2032) Figure 60. Asia Saxagliptin Sales Share by Country (2021-2032) Figure 61. SAMEA Saxagliptin Revenue Share by Type (2021-2032) Figure 62. SAMEA Saxagliptin Sales Share by Type (2021-2032) Figure 63. SAMEA Saxagliptin Revenue Share by Application (2021-2032) Figure 64. SAMEA Saxagliptin Sales Share by Application (2021-2032) Figure 65. SAMEA Saxagliptin Revenue Share by Country (2021-2032) Figure 66. SAMEA Saxagliptin Sales Share by Country (2021-2032) Figure 67. Saxagliptin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Saxagliptin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5mg
  • 5mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Bristol-Myers Squibb Company
  • Minxiang Pharma
  • Taizhou Canova Bio-technology
  • Tapi Teva
  • AstraZeneca
  • Hebei Kangtai Pharma
  • Huaman Xincaiiao Keji
  • Tianjin Scipharmacn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Saxagliptin Market by Type
  3. 1.2.1 Global Saxagliptin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 2.5mg
  5. 1.2.3 5mg
  6. 1.3 Saxagliptin Market by Application
  7. 1.3.1 Global Saxagliptin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Saxagliptin Market Dynamics
  1. 2.1 Saxagliptin Industry Trends
  2. 2.2 Saxagliptin Industry Drivers
  3. 2.3 Saxagliptin Industry Opportunities and Challenges
  4. 2.4 Saxagliptin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Saxagliptin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Saxagliptin Revenue by Region
  3. 3.2.1 Global Saxagliptin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Saxagliptin Revenue by Region (2021-2026)
  5. 3.2.3 Global Saxagliptin Revenue by Region (2027-2032)
  6. 3.2.4 Global Saxagliptin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Saxagliptin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Saxagliptin Sales by Region
  9. 3.4.1 Global Saxagliptin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Saxagliptin Sales by Region (2021-2026)
  11. 3.4.3 Global Saxagliptin Sales by Region (2027-2032)
  12. 3.4.4 Global Saxagliptin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Saxagliptin Revenue by Manufacturers
  2. 4.1.1 Global Saxagliptin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Saxagliptin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Saxagliptin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Saxagliptin Sales by Manufacturers
  6. 4.2.1 Global Saxagliptin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Saxagliptin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Saxagliptin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Saxagliptin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Saxagliptin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Saxagliptin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Saxagliptin Manufacturers, Product Type & Application
  13. 4.7 Global Saxagliptin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Saxagliptin Market CR5 and HHI
  16. 4.8.2 2025 Saxagliptin Tier 1, Tier 2, and Tier 3
5 Saxagliptin Market by Type
  1. 5.1 Global Saxagliptin Revenue by Type
  2. 5.1.1 Global Saxagliptin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Saxagliptin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Saxagliptin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Saxagliptin Sales by Type
  6. 5.2.1 Global Saxagliptin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Saxagliptin Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Saxagliptin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Saxagliptin Price by Type
6 Saxagliptin Market by Application
  1. 6.1 Global Saxagliptin Revenue by Application
  2. 6.1.1 Global Saxagliptin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Saxagliptin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Saxagliptin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Saxagliptin Sales by Application
  6. 6.2.1 Global Saxagliptin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Saxagliptin Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Saxagliptin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Saxagliptin Price by Application
7 Company Profiles
  1. 7.1 Bristol-Myers Squibb Company
  2. 7.1.1 Bristol-Myers Squibb Company Company Information
  3. 7.1.2 Bristol-Myers Squibb Company Business Overview
  4. 7.1.3 Bristol-Myers Squibb Company Saxagliptin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bristol-Myers Squibb Company Saxagliptin Product Portfolio
  6. 7.1.5 Bristol-Myers Squibb Company Recent Developments
  7. 7.2 Minxiang Pharma
  8. 7.2.1 Minxiang Pharma Company Information
  9. 7.2.2 Minxiang Pharma Business Overview
  10. 7.2.3 Minxiang Pharma Saxagliptin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Minxiang Pharma Saxagliptin Product Portfolio
  12. 7.2.5 Minxiang Pharma Recent Developments
  13. 7.3 Taizhou Canova Bio-technology
  14. 7.3.1 Taizhou Canova Bio-technology Company Information
  15. 7.3.2 Taizhou Canova Bio-technology Business Overview
  16. 7.3.3 Taizhou Canova Bio-technology Saxagliptin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Taizhou Canova Bio-technology Saxagliptin Product Portfolio
  18. 7.3.5 Taizhou Canova Bio-technology Recent Developments
  19. 7.4 Tapi Teva
  20. 7.4.1 Tapi Teva Company Information
  21. 7.4.2 Tapi Teva Business Overview
  22. 7.4.3 Tapi Teva Saxagliptin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Tapi Teva Saxagliptin Product Portfolio
  24. 7.4.5 Tapi Teva Recent Developments
  25. 7.5 AstraZeneca
  26. 7.5.1 AstraZeneca Company Information
  27. 7.5.2 AstraZeneca Business Overview
  28. 7.5.3 AstraZeneca Saxagliptin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AstraZeneca Saxagliptin Product Portfolio
  30. 7.5.5 AstraZeneca Recent Developments
  31. 7.6 Hebei Kangtai Pharma
  32. 7.6.1 Hebei Kangtai Pharma Company Information
  33. 7.6.2 Hebei Kangtai Pharma Business Overview
  34. 7.6.3 Hebei Kangtai Pharma Saxagliptin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hebei Kangtai Pharma Saxagliptin Product Portfolio
  36. 7.6.5 Hebei Kangtai Pharma Recent Developments
  37. 7.7 Huaman Xincaiiao Keji
  38. 7.7.1 Huaman Xincaiiao Keji Company Information
  39. 7.7.2 Huaman Xincaiiao Keji Business Overview
  40. 7.7.3 Huaman Xincaiiao Keji Saxagliptin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Huaman Xincaiiao Keji Saxagliptin Product Portfolio
  42. 7.7.5 Huaman Xincaiiao Keji Recent Developments
  43. 7.8 Tianjin Scipharmacn
  44. 7.8.1 Tianjin Scipharmacn Company Information
  45. 7.8.2 Tianjin Scipharmacn Business Overview
  46. 7.8.3 Tianjin Scipharmacn Saxagliptin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Tianjin Scipharmacn Saxagliptin Product Portfolio
  48. 7.8.5 Tianjin Scipharmacn Recent Developments
8 North America
  1. 8.1 North America Saxagliptin Market Size by Type
  2. 8.1.1 North America Saxagliptin Revenue by Type (2021-2032)
  3. 8.1.2 North America Saxagliptin Sales by Type (2021-2032)
  4. 8.1.3 North America Saxagliptin Price by Type (2021-2032)
  5. 8.2 North America Saxagliptin Market Size by Application
  6. 8.2.1 North America Saxagliptin Revenue by Application (2021-2032)
  7. 8.2.2 North America Saxagliptin Sales by Application (2021-2032)
  8. 8.2.3 North America Saxagliptin Price by Application (2021-2032)
  9. 8.3 North America Saxagliptin Market Size by Country
  10. 8.3.1 North America Saxagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Saxagliptin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Saxagliptin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Saxagliptin Market Size by Type
  2. 9.1.1 Europe Saxagliptin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Saxagliptin Sales by Type (2021-2032)
  4. 9.1.3 Europe Saxagliptin Price by Type (2021-2032)
  5. 9.2 Europe Saxagliptin Market Size by Application
  6. 9.2.1 Europe Saxagliptin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Saxagliptin Sales by Application (2021-2032)
  8. 9.2.3 Europe Saxagliptin Price by Application (2021-2032)
  9. 9.3 Europe Saxagliptin Market Size by Country
  10. 9.3.1 Europe Saxagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Saxagliptin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Saxagliptin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Saxagliptin Market Size by Type
  2. 10.1.1 China Saxagliptin Revenue by Type (2021-2032)
  3. 10.1.2 China Saxagliptin Sales by Type (2021-2032)
  4. 10.1.3 China Saxagliptin Price by Type (2021-2032)
  5. 10.2 China Saxagliptin Market Size by Application
  6. 10.2.1 China Saxagliptin Revenue by Application (2021-2032)
  7. 10.2.2 China Saxagliptin Sales by Application (2021-2032)
  8. 10.2.3 China Saxagliptin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Saxagliptin Market Size by Type
  2. 11.1.1 Asia Saxagliptin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Saxagliptin Sales by Type (2021-2032)
  4. 11.1.3 Asia Saxagliptin Price by Type (2021-2032)
  5. 11.2 Asia Saxagliptin Market Size by Application
  6. 11.2.1 Asia Saxagliptin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Saxagliptin Sales by Application (2021-2032)
  8. 11.2.3 Asia Saxagliptin Price by Application (2021-2032)
  9. 11.3 Asia Saxagliptin Market Size by Country
  10. 11.3.1 Asia Saxagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Saxagliptin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Saxagliptin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Saxagliptin Market Size by Type
  2. 12.1.1 SAMEA Saxagliptin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Saxagliptin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Saxagliptin Price by Type (2021-2032)
  5. 12.2 SAMEA Saxagliptin Market Size by Application
  6. 12.2.1 SAMEA Saxagliptin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Saxagliptin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Saxagliptin Price by Application (2021-2032)
  9. 12.3 SAMEA Saxagliptin Market Size by Country
  10. 12.3.1 SAMEA Saxagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Saxagliptin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Saxagliptin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Saxagliptin Value Chain Analysis
  2. 13.1.1 Saxagliptin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Saxagliptin Production Mode & Process
  6. 13.2 Saxagliptin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Saxagliptin Distributors
  9. 13.2.3 Saxagliptin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst